BRCA1 and breast cancer: Due to a substantial gain of knowledge about the clinical risk and outcome of patients with high risk mutations such as BRCA1 and 2, improved diagnostic possibilities for detecting the genetic predisposition for the development of breast cancer and the awareness for those mutations by health care professionals as well as patients, the demand for prophylactic mastectomy has increased significantly over the last 10 years.